Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prepare: RSV F Vaccine in Pregnant Women
NCT02624947Phase 3Completed
- Sponsor
- Novavax
- Start
- Dec 2015
- Primary completion
- Dec 2018
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 11
01
Overview
A Phase 3 trial of RSV F vaccine + aluminum phosphate in respiratory syncytial virus infection (RSV), sponsored by Novavax. Started Dec 2015; status: completed.
02
Drugs
RSV F vaccine + aluminum phosphate
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT02624947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624947.